文献速递产科母胎医学

低剂量阿司匹林在低风险初产妇妊娠中的应用:随机对照试验的系统综述与Meta分析

Low-dose aspirin use in low-risk nulliparous pregnancies: a systematic review and meta-analysis of randomized controlled trials.
PubMed 文献 · Am J Obstet Gynecol MFM · 2025-01-02

该系统综述与Meta分析纳入10项随机对照试验共27,075例低风险初产妇单胎妊娠,评估低剂量阿司匹林预防不良结局的疗效。结果显示低剂量阿司匹林与对照组在早产<37周和<34周风险上无显著差异,但每日100 mg阿司匹林且在16周前开始者早产<37周风险显著降低(RR 0.45,95%CI 0.35-0.59)。结论认为每日100 mg阿司匹林可降低低风险初产妇早产<37周发生率,16周前开始可能最有帮助。

要点

  • 低剂量阿司匹林与对照组相比,早产<37周(RR 0.90,95%CI 0.73-1.09)和<34周(RR 0.62,95%CI 0.37-1.05)风险无显著差异。
  • 每日100 mg阿司匹林且在16周前开始者,早产<37周风险显著降低(RR 0.45,95%CI 0.35-0.59)。
  • 每日100 mg阿司匹林者早产<37周风险低于每日60-81 mg者(RR 0.39,95%CI 0.31-0.48)。

核心结论

  • 每日100 mg低剂量阿司匹林可降低低风险初产妇妊娠早产<37周的发生率,16周前开始可能最有帮助。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Ovid MEDLINE、Scopus、Cochrane Library、clinicaltrials.gov和ScienceDirect从建库至2023年8月5日。
  • 纳入比较低剂量阿司匹林与安慰剂或不治疗的低风险初产妇单胎妊娠随机临床试验,排除高危妊娠(包括既往早产、既往子痫前期、母体糖尿病或慢性高血压)。
  • 共纳入10项试验,包括27,075例低风险初产妇妊娠。

主要发现

  • 低剂量阿司匹林与对照组相比,早产<37周风险无显著差异(RR 0.90,95%CI 0.73-1.09)。
  • 低剂量阿司匹林与对照组相比,早产<34周风险无显著差异(RR 0.62,95%CI 0.37-1.05)。
  • 16周前开始每日100 mg阿司匹林者早产<37周风险显著降低(RR 0.45,95%CI 0.35-0.59)。
  • 16周后开始每日100 mg阿司匹林者早产<37周风险降低幅度较小(RR 0.88,95%CI 0.80-0.97)。
  • 每日100 mg阿司匹林者早产<37周风险低于每日60-81 mg者(RR 0.39,95%CI 0.31-0.48)。

关键数值与推荐

  • 主要结局为早产<37周的发生率。
  • 效应量以相对风险(RR)或均数差(MD)及95%置信区间(CI)报告。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the efficacy of low-dose aspirin in the prevention of adverse outcomes in low-risk, nulliparous singleton pregnancies. DATA SOURCES: PubMed, Ovid MEDLINE, Scopus, Cochrane Library, clinicaltrials.gov, and ScienceDirect were searched from their inception to August 5, 2023. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Randomized clinical trials comparing low-dose aspirin with placebo or with no treatment in low-risk nulliparous singleton pregnancies were included. High-risk pregnancies, including prior preterm birth, prior preeclampsia, and those affected by maternal diabetes or chronic hypertension were excluded. DATA APPRAISAL AND SYNTHESIS METHODS: The primary outcome was the incidence of preterm delivery at less than 37 weeks. The summary measures were reported as relative risk (RR) or as mean difference (MD) with a 95% confidence interval (CI). RESULTS: Ten trials, including 27,075 nulliparous low-risk pregnancies, were included. Overall, low-dose aspirin was associated with no significant differences in preterm birth less than 37 weeks (RR 0.90, 95% CI 0.73-1.09) and less than 34 weeks (RR 0.62, 95% CI 0.37-1.05) compared to control. Patients who took 100 mg daily of aspirin prior to 16 weeks had a significantly lower risk of preterm birth at less than 37 weeks (RR: 0.45, 95% CI: 0.35-0.59), as did, to a lower magnitude, those who began aspirin 100 mg daily after 16 weeks (RR: 0.88, 95% CI: 0.80-0.97). Those who took 100 mg daily of aspirin were at a lower risk of preterm birth at less than 37 weeks than those who took between 60 and 81 mg of daily aspirin (RR: 0.39, 95% CI: 0.31-0.48). No statistically significant differences were found in the incidence of hypertensive disorders of pregnancy, perinatal or neonatal death. CONCLUSIONS: Low-dose aspirin at 100 mg daily reduces the incidence of preterm birth at less than 37 weeks in low-risk, nulliparous pregnancies and may be most helpful if initiated prior to 16 weeks. El resumen está disponible en Español al final del artículo.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Wodoslawsky S, Khanuja K, Saccone G, et al. Low-dose aspirin use in low-risk nulliparous pregnancies: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol MFM. 2025. PMID: 39755251. doi:10.1016/j.ajogmf.2024.101595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。